Tumor Hypoxia Detected by Positron Emission Tomography with (60)Cu-ATSM as a Predictor of Response and Survival in Patients Undergoing Neoadjuvant Chemoradiotherapy for Rectal Carcinoma: A Pilot Study

PURPOSE: The response of rectal cancers to neoadjuvant chemoradiotherapy is variable. Tumor hypoxia reduces the effectiveness of both radiation therapy and chemotherapy and is a well-known risk factor for tumor radioresistence. We hypothesized that imaging with the novel hypoxia-detecting agent, (60...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Dis Colon Rectum
Egile Nagusiak: Dietz, David W., Dehdashti, Farrokh, Grigsby, Perry W., Malyapa, Robert S., Myerson, Robert J., Picus, Joel, Ritter, Jon, Lewis, Jason S., Welch, Michael J., Siegel, Barry A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4962601/
https://ncbi.nlm.nih.gov/pubmed/18682881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10350-008-9420-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak